lansoprazole has been researched along with Infant, Premature, Diseases in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " 10 infants suspected of having GERD (gastroesophageal reflux) received oral lansoprazole therapy by tube administration." | 3.78 | Does oral lansoprazole really reduce gastric acidity in VLBW premature neonates? ( Ong, KK; Rogers, IM; Samuel, KF; Singh, A; Tham, SY, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tham, SY | 1 |
| Rogers, IM | 1 |
| Samuel, KF | 1 |
| Singh, A | 1 |
| Ong, KK | 1 |
| Reynolds, EW | 1 |
| Kinnard, TB | 1 |
| Kriss, VM | 1 |
| Perman, JA | 1 |
2 other studies available for lansoprazole and Infant, Premature, Diseases
| Article | Year |
|---|---|
Does oral lansoprazole really reduce gastric acidity in VLBW premature neonates?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Female; Gastric Acid; Gastroesophageal R | 2012 |
Superior mesenteric artery syndrome: an uncommon cause of feeding intolerance in infancy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dexamethasone; Enteral Nutrition; Gastroesophageal Reflux; | 2008 |